Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	spermine oxidase activity	PAOX SMOX	2.84e-05	2	107	2	GO:0052901
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYH9 MYH7B MYH14 DYNC1H1 DNAH11	4.17e-05	118	107	6	GO:0003774
GeneOntologyMolecularFunction	polyamine oxidase activity	PAOX SMOX	8.50e-05	3	107	2	GO:0046592
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DYNC1H1 DNAH11	1.15e-04	18	107	3	GO:0008569
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor	PAOX SMOX	1.69e-04	4	107	2	GO:0016647
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DYNC1H1 DNAH11	4.45e-04	28	107	3	GO:0051959
GeneOntologyBiologicalProcess	vesicle tethering to endoplasmic reticulum	STARD3 STARD3NL	2.62e-05	2	106	2	GO:0099044
GeneOntologyBiologicalProcess	response to fluid shear stress	CITED2 PTK2B CSF2 PKD1	3.05e-05	35	106	4	GO:0034405
GeneOntologyCellularComponent	myosin II filament	MYH9 MYH14	8.05e-05	3	109	2	GO:0097513
GeneOntologyCellularComponent	endoplasmic reticulum-endosome membrane contact site	STARD3 STARD3NL	1.61e-04	4	109	2	GO:0140284
GeneOntologyCellularComponent	apical plasma membrane	MYH9 CASR CUBN LCT MFSD4B SLC5A1 KCNC2 P2RY4 CYP4F12 PLD1	2.34e-04	487	109	10	GO:0016324
GeneOntologyCellularComponent	apical part of cell	MYH9 CASR CUBN PTCH1 LCT MFSD4B SLC5A1 KCNC2 P2RY4 CYP4F12 PLD1	2.68e-04	592	109	11	GO:0045177
GeneOntologyCellularComponent	myosin filament	MYH9 MYH7B MYH14	2.92e-04	25	109	3	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH9 MYH7B MYH14	4.11e-04	28	109	3	GO:0016460
Domain	MENTAL	STARD3 STARD3NL	3.31e-05	2	108	2	PF10457
Domain	MENTAL	STARD3 STARD3NL	3.31e-05	2	108	2	PS51439
Domain	MENTAL	STARD3 STARD3NL	3.31e-05	2	108	2	IPR019498
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	IPR013602
Domain	DHC_N2	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	IPR011704
Domain	MT	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	PF12777
Domain	AAA_8	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	PF12780
Domain	AAA_5	DNAH3 DYNC1H1 DNAH11	6.53e-05	14	108	3	PF07728
Domain	DHC_fam	DNAH3 DYNC1H1 DNAH11	8.13e-05	15	108	3	IPR026983
Domain	Dynein_heavy	DNAH3 DYNC1H1 DNAH11	8.13e-05	15	108	3	PF03028
Domain	Myosin_N	MYH9 MYH7B MYH14	8.13e-05	15	108	3	PF02736
Domain	Dynein_heavy_dom	DNAH3 DYNC1H1 DNAH11	8.13e-05	15	108	3	IPR004273
Domain	Myosin_N	MYH9 MYH7B MYH14	8.13e-05	15	108	3	IPR004009
Domain	Myosin_tail_1	MYH9 MYH7B MYH14	1.44e-04	18	108	3	PF01576
Domain	Myosin_tail	MYH9 MYH7B MYH14	1.44e-04	18	108	3	IPR002928
Domain	Myosin-like_IQ_dom	MYH9 MYH7B MYH14	1.70e-04	19	108	3	IPR027401
Domain	-	MYH9 MYH7B MYH14	1.70e-04	19	108	3	4.10.270.10
Domain	DHC_N1	DYNC1H1 DNAH11	9.07e-04	8	108	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC1H1 DNAH11	9.07e-04	8	108	2	IPR013594
Domain	Myosin_head_motor_dom	MYH9 MYH7B MYH14	1.37e-03	38	108	3	IPR001609
Domain	MYOSIN_MOTOR	MYH9 MYH7B MYH14	1.37e-03	38	108	3	PS51456
Domain	Myosin_head	MYH9 MYH7B MYH14	1.37e-03	38	108	3	PF00063
Domain	MYSc	MYH9 MYH7B MYH14	1.37e-03	38	108	3	SM00242
Domain	Amino_oxidase	PAOX SMOX	1.45e-03	10	108	2	IPR002937
Domain	Cyt_P450_E_grp-IV	CYP39A1 CYP4F12	1.45e-03	10	108	2	IPR002403
Domain	Amino_oxidase	PAOX SMOX	1.45e-03	10	108	2	PF01593
Domain	uDENN	DENND1B SBF2	2.88e-03	14	108	2	SM00800
Domain	uDENN	DENND1B SBF2	3.31e-03	15	108	2	PF03456
Domain	ARM-type_fold	RELCH DNAJC13 SARM1 INTS1 PPP2R5C EIF4G1 ATM	3.56e-03	339	108	7	IPR016024
Domain	DENN	DENND1B SBF2	3.77e-03	16	108	2	SM00799
Domain	DENN	DENND1B SBF2	3.77e-03	16	108	2	PF02141
Domain	dDENN	DENND1B SBF2	3.77e-03	16	108	2	PF03455
Domain	UDENN	DENND1B SBF2	3.77e-03	16	108	2	PS50946
Domain	DDENN	DENND1B SBF2	3.77e-03	16	108	2	PS50947
Domain	dDENN	DENND1B SBF2	3.77e-03	16	108	2	SM00801
Domain	dDENN_dom	DENND1B SBF2	3.77e-03	16	108	2	IPR005112
Domain	uDENN_dom	DENND1B SBF2	3.77e-03	16	108	2	IPR005113
Domain	DENN	DENND1B SBF2	3.77e-03	16	108	2	PS50211
Domain	DENN_dom	DENND1B SBF2	3.77e-03	16	108	2	IPR001194
Domain	CYTOCHROME_P450	CYP19A1 CYP39A1 CYP4F12	4.39e-03	57	108	3	PS00086
Domain	-	CYP19A1 CYP39A1 CYP4F12	4.61e-03	58	108	3	1.10.630.10
Domain	p450	CYP19A1 CYP39A1 CYP4F12	4.61e-03	58	108	3	PF00067
Domain	Cyt_P450	CYP19A1 CYP39A1 CYP4F12	5.07e-03	60	108	3	IPR001128
Pubmed	Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.	CYP19A1 BRCA2 STARD3 ATM MMP13 EP300	1.94e-06	117	109	6	19124506
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MYH9 MYH7B COPB2 NAP1L1 TMEM43 ISG15 EIF4G1 DYNC1H1	2.17e-06	268	109	8	33024031
Pubmed	Foxj1 regulates floor plate cilia architecture and modifies the response of cells to sonic hedgehog signalling.	PTCH1 DNAH11 FOXJ1	3.54e-06	10	109	3	21098568
Pubmed	Discovery and refinement of loci associated with lipid levels.	DNAJC13 CUBN CITED2 BRCA2 STARD3 FUT2 DNAH11	4.83e-06	211	109	7	24097068
Pubmed	Functional characterization of the MENTAL domain.	STARD3 STARD3NL	9.73e-06	2	109	2	15718238
Pubmed	Mutation of the mouse hepatocyte nuclear factor/forkhead homologue 4 gene results in an absence of cilia and random left-right asymmetry.	DNAH11 FOXJ1	9.73e-06	2	109	2	9739041
Pubmed	[Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].	PTCH1 ATM	9.73e-06	2	109	2	15142440
Pubmed	MENTHO, a MLN64 homologue devoid of the START domain.	STARD3 STARD3NL	9.73e-06	2	109	2	12393907
Pubmed	Differentiation of mouse bone marrow derived stem cells toward microglia-like cells.	FLT3 CSF2	9.73e-06	2	109	2	21854582
Pubmed	Touché! STARD3 and STARD3NL tether the ER to endosomes.	STARD3 STARD3NL	9.73e-06	2	109	2	27068960
Pubmed	Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization.	PAOX SMOX	9.73e-06	2	109	2	15247269
Pubmed	Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.	BRCA2 ATM	9.73e-06	2	109	2	37126020
Pubmed	Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease.	PKD1 ATM	9.73e-06	2	109	2	33802342
Pubmed	Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion.	PAOX SMOX	9.73e-06	2	109	2	12477380
Pubmed	Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer.	BRCA2 ATM	9.73e-06	2	109	2	27692705
Pubmed	The FOXJ1 target Cfap206 is required for sperm motility, mucociliary clearance of the airways and brain development.	CFAP206 FOXJ1	9.73e-06	2	109	2	32376681
Pubmed	Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer.	BRCA2 ATM	9.73e-06	2	109	2	34533610
Pubmed	Differential Contributions of Ubiquitin-Modified APOBEC3G Lysine Residues to HIV-1 Vif-Induced Degradation.	APOBEC3G UBA1	9.73e-06	2	109	2	27297094
Pubmed	Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney Disease.	PKD1 ATM	9.73e-06	2	109	2	36293397
Pubmed	Distinct roles of nonmuscle myosin II isoforms for establishing tension and elasticity during cell morphodynamics.	MYH9 MYH14	9.73e-06	2	109	2	34374341
Pubmed	Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells.	VWF PLD1	9.73e-06	2	109	2	18945966
Pubmed	MLN64 and MENTHO, two mediators of endosomal cholesterol transport.	STARD3 STARD3NL	9.73e-06	2	109	2	16709157
Pubmed	Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population.	CASR LCT	9.73e-06	2	109	2	18980667
Pubmed	Non-muscle myosin IIA is post-translationally modified by interferon-stimulated gene 15 in breast cancer cells.	MYH9 ISG15	9.73e-06	2	109	2	30529400
Pubmed	The B subunits of Shiga-like toxins induce regulated VWF secretion in a phospholipase D1-dependent manner.	VWF PLD1	9.73e-06	2	109	2	22718838
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DYNC1H1 DNAH11	1.06e-05	14	109	3	9373155
Pubmed	Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation.	PTCH1 EP300 FOXJ1	1.33e-05	15	109	3	14517255
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	MYH9 CORO1C ECD NAP1L1 EPS15L1 EIF4G1 DYNC1H1	1.70e-05	256	109	7	33397691
Pubmed	Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos.	PTCH1 CITED2 EP300	1.97e-05	17	109	3	18330926
Pubmed	BioID-based proteomic analysis of the Bid interactome identifies novel proteins involved in cell-cycle-dependent apoptotic priming.	EPS15L1 MYH14 EIF4G1 DYNC1H1	2.75e-05	55	109	4	33067418
Pubmed	BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC.	BRCA2 MYH14	2.91e-05	3	109	2	24448238
Pubmed	Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.	DYNC1H1 DNAH11	2.91e-05	3	109	2	22887640
Pubmed	NAP1L1 Promotes Endometrial Cancer Progression via EP300-Mediated DDX5 Promoter Acetylation.	NAP1L1 EP300	2.91e-05	3	109	2	38953887
Pubmed	Purinergic receptors expressed in human skeletal muscle fibres.	P2RY4 P2RY11	2.91e-05	3	109	2	22052557
Pubmed	BRCA2 is required for neurogenesis and suppression of medulloblastoma.	BRCA2 ATM	2.91e-05	3	109	2	17476307
Pubmed	Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.	BRCA2 ATM	2.91e-05	3	109	2	15084244
Pubmed	Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.	BRCA2 ATM	2.91e-05	3	109	2	32875559
Pubmed	Planar polarity of multiciliated ependymal cells involves the anterior migration of basal bodies regulated by non-muscle myosin II.	MYH9 MYH14	2.91e-05	3	109	2	20685736
Pubmed	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.	BRCA2 BUB1	2.91e-05	3	109	2	14646599
Pubmed	The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription.	NAP1L1 EP300	2.91e-05	3	109	2	18226242
Pubmed	BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.	BRCA2 ATM	2.91e-05	3	109	2	33414135
Pubmed	B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation.	PPP2R5C EP300	2.91e-05	3	109	2	15632055
Pubmed	Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.	BRCA2 ATM	2.91e-05	3	109	2	17333338
Pubmed	Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.	MYH9 MYH14	2.91e-05	3	109	2	15177565
Pubmed	Phosphorylation of p300 by ATM controls the stability of NBS1.	ATM EP300	2.91e-05	3	109	2	20471956
Pubmed	Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription.	NAP1L1 EP300	2.91e-05	3	109	2	14966293
Pubmed	Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells.	ATM MMP13	2.91e-05	3	109	2	27556690
Pubmed	A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway.	ISG15 ATM	2.91e-05	3	109	2	21298066
Pubmed	Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.	BRCA2 ATM	2.91e-05	3	109	2	16574953
Pubmed	Is olaparib cost effective in metastatic castration-resistant prostate cancer patients with at least one favorable gene mutation in BRCA1, BRCA2 or ATM?	BRCA2 ATM	2.91e-05	3	109	2	34517749
Pubmed	Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.	CITED2 EP300	2.91e-05	3	109	2	12778114
Pubmed	Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.	MYH9 MYH14	2.91e-05	3	109	2	15774463
Pubmed	Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.	BRCA2 ATM	2.91e-05	3	109	2	29915322
Pubmed	DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities.	BRCA2 ATM	2.91e-05	3	109	2	27317574
Pubmed	Down-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cells.	BRCA2 ISG15	2.91e-05	3	109	2	15670748
Pubmed	CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.	CITED2 EP300	2.91e-05	3	109	2	17906695
Pubmed	ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.	FLT3 ATM	2.91e-05	3	109	2	27791036
Pubmed	The chromatin remodeler CHD8 governs hematopoietic stem/progenitor survival by regulating ATM-mediated P53 protein stability.	CHD8 ATM	2.91e-05	3	109	2	34292326
Pubmed	Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family.	MYH9 MYH14	2.91e-05	3	109	2	14594953
Pubmed	Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.	PAOX SMOX	2.91e-05	3	109	2	16207710
Pubmed	Characterization of three full-length human nonmuscle myosin II paralogs.	MYH9 MYH14	2.91e-05	3	109	2	24072716
Pubmed	Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.	MYH9 MYH14	2.91e-05	3	109	2	15845534
Pubmed	Effect of germ-line genetic variation on breast cancer survival in a population-based study.	CYP19A1 BRCA2 ATM	3.28e-05	20	109	3	12036913
Pubmed	Altered heparan sulfate structure in Glce(-/-) mice leads to increased Hedgehog signaling in endochondral bones.	PTCH1 COL18A1 MMP13	3.82e-05	21	109	3	26116392
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ENGASE PLXNA3 INTS1 CHD8 PTCH1 EPS15L1 SYNJ1 SBF2 EIF4G1 PKD1 EP300 SOWAHB DYNC1H1	4.37e-05	1105	109	13	35748872
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH9 DNAJC13 NAP1L1 PARP14 MYH14 EIF4G1	4.39e-05	202	109	6	33005030
Pubmed	Genetic mutations associated with cigarette smoking in pancreatic cancer.	FLT3 PTCH1 BRCA2 ATM	4.72e-05	63	109	4	19351817
Pubmed	PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation.	TENT4B ATM PLD1	5.78e-05	24	109	3	24710276
Pubmed	Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.	BRCA2 ATM	5.82e-05	4	109	2	20513533
Pubmed	Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.	BRCA2 ATM	5.82e-05	4	109	2	17428320
Pubmed	Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family.	MYH7B MYH14	5.82e-05	4	109	2	11919279
Pubmed	Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.	CASR EP300	5.82e-05	4	109	2	19456861
Pubmed	A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.	BRCA2 ATM	5.82e-05	4	109	2	27941124
Pubmed	The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis.	BUB1 ATM	5.82e-05	4	109	2	20663956
Pubmed	Elevated HMGN4 expression potentiates thyroid tumorigenesis.	BRCA2 ATM	5.82e-05	4	109	2	28186538
Pubmed	ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.	ATM EP300	5.82e-05	4	109	2	29352223
Pubmed	Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping.	MYH9 MYH14	5.82e-05	4	109	2	18697221
Pubmed	Three types of cilia including a novel 9+4 axoneme on the notochordal plate of the rabbit embryo.	DNAH11 FOXJ1	5.82e-05	4	109	2	17061268
Pubmed	Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro.	NAP1L1 EP300	5.82e-05	4	109	2	11940655
Pubmed	Gene-gene interactions in breast cancer susceptibility.	BRCA2 ATM	5.82e-05	4	109	2	22072393
Pubmed	FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2.	CITED2 EP300	5.82e-05	4	109	2	25956243
Pubmed	Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation.	FLT3 CSF2	5.82e-05	4	109	2	19151789
Pubmed	FLT3/ ITD regulates leukaemia cell adhesion through α4β1 integrin and Pyk2 signalling.	FLT3 PTK2B	5.82e-05	4	109	2	21114537
Pubmed	Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.	CITED2 EP300	5.82e-05	4	109	2	9887100
Pubmed	STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER.	STARD3 STARD3NL	5.82e-05	4	109	2	24105263
Pubmed	Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.	FLT3 CSF2	5.82e-05	4	109	2	9345066
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CORO1C NAP1L1 CHD8 EPS15L1 UBA1 SYNJ1 RAB3GAP2 EP300 DYNC1H1	6.00e-05	549	109	9	38280479
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	MYH9 ELP5 CORO1C ECD EPS15L1 EIF4G1	6.37e-05	216	109	6	31519766
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	CORO1C ECD COPB2 EPS15L1 UBA1 PPP2R5C SHCBP1 BUB1 EIF4G1 ANAPC16 ATM PRRC1 DYNC1H1	6.84e-05	1155	109	13	20360068
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MYH9 NAP1L1 CHD8 EPS15L1 UBA1 BRCA2 MYH14 EIF4G1	8.17e-05	444	109	8	34795231
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	MYH9 UBTD2 CHD8 PARP14 EIF4G1 EP300 DYNC1H1	8.79e-05	332	109	7	37433992
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	MYH9 COPB2 NAP1L1 UBA1 CDC123 MYH14 DYNC1H1	9.12e-05	334	109	7	30425250
Pubmed	Vpr and its interactions with cellular proteins.	APOBEC3G ATM EP300	9.27e-05	28	109	3	20012529
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	MYH9 DNAJC13 COPB2 INTS1 CHD8 ORC4 BUB1 ATM DYNC1H1	9.36e-05	582	109	9	20467437
Pubmed	Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein.	CITED2 EP300	9.67e-05	5	109	2	11581164
Pubmed	Myosin II regulates extension, growth and patterning in the mammalian cochlear duct.	MYH9 MYH14	9.67e-05	5	109	2	19439495
Pubmed	Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.	BRCA2 ATM	9.67e-05	5	109	2	18642075
Pubmed	Multiscale analysis of single and double maternal-zygotic Myh9 and Myh10 mutants during mouse preimplantation development.	MYH9 MYH14	9.67e-05	5	109	2	33871354
Pubmed	Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF).	KLF1 EP300	9.67e-05	5	109	2	21670263
Pubmed	Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.	BRCA2 ATM	9.67e-05	5	109	2	17428325
GeneFamily	Myosin heavy chains	MYH9 MYH7B MYH14	2.34e-05	15	69	3	1098
GeneFamily	Purinergic receptors P2Y	P2RY4 P2RY11	6.33e-04	10	69	2	213
GeneFamily	Dyneins, axonemal	DNAH3 DNAH11	1.88e-03	17	69	2	536
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND1B SBF2	4.07e-03	25	69	2	504
Coexpression	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	TENT4B APOBEC3G GSAP PARP14 SLC5A1 CITED2 PAOX RASGRP3 ARHGAP25 FUT2 SMOX MMP13 SOWAHB ZNF44	4.75e-07	644	109	14	M34026
Coexpression	JOHNSTONE_PARVB_TARGETS_3_UP	MYH9 NAP1L1 TMEM43 GSAP CITED2 COL18A1 EIF4G1 ATM PLD1 DYNC1H1	1.36e-05	433	109	10	M2240
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN	NAP1L1 ANAPC16 ATM	1.50e-05	12	109	3	M41057
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN	NAP1L1 ANAPC16 ATM	1.94e-05	13	109	3	M40915
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	FLT3 UBTD2 LAYN NAP1L1 TMEM43 GSAP SEMA3G ATP8B2 PTK2B SYNJ1 KLF1 DROSHA STARD3 ARHGAP25 CYP4F12 SMOX MMP13	3.02e-05	1316	109	17	MM1052
ToppCell	droplet-Fat-Gat-18m-Hematologic\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SHCBP1 SMOX	3.18e-06	164	109	6	7dbe34a98a3b475c1ba678db8a5494c0c6a91e2d
ToppCell	droplet-Fat-Gat-18m-Hematologic-erythroblast\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SHCBP1 SMOX	3.18e-06	164	109	6	febcb8f8b305aa94e21131fa83d2890f7a6838fc
ToppCell	droplet-Fat-Gat-18m-Hematologic-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SHCBP1 SMOX	3.29e-06	165	109	6	1e89154114327650df39befb2c56d0379ea6a221
ToppCell	metastatic_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	COPB2 PTCH1 CYP39A1 SLC5A1 HECTD2 ZNF44	4.18e-06	172	109	6	c3822ff7329c3ac38c68c5c38cd67c390682e2a6
ToppCell	P07-Epithelial-airway_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	6.16e-06	184	109	6	a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCell	P07-Epithelial-airway_epithelial_cell-club_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	6.16e-06	184	109	6	ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCell	P28-Epithelial-airway_epithelial_cell-club_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	6.55e-06	186	109	6	a26811481668fa25c48a064a56c198685693ad8d
ToppCell	P28-Epithelial-airway_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	6.55e-06	186	109	6	df80f101954b8ec6ccdb03e702de22e70b65181f
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	7.18e-06	189	109	6	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	7.18e-06	189	109	6	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NAP1L1 PARP14 PPP2R5C BRCA2 RASGRP3 ATM	7.18e-06	189	109	6	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 DNAH11 FOXJ1	7.18e-06	189	109	6	a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCell	facs-Bladder-nan-3m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECD PTK2B COL18A1 UBA1 ASPH SOWAHB	8.33e-06	194	109	6	e74cd8cf3763f6adbfd1c269a886a806049714cf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYH9 VWF SLC38A5 SEMA3G ERVMER34-1 RASGRP3	8.33e-06	194	109	6	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYH9 VWF SLC38A5 SEMA3G ERVMER34-1 RASGRP3	8.33e-06	194	109	6	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	mild-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLC38A5 PAOX BRCA2 RASGRP3 SHCBP1 BUB1	9.09e-06	197	109	6	21085d5e27b5a23a241a933058bb89f8a1fcf198
ToppCell	severe-Plasmablast\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	COPB2 SLC38A5 PAOX RASGRP3 SHCBP1 BUB1	9.36e-06	198	109	6	0b1620ad4352ee5d599a72931aaceab4ca407498
ToppCell	mild-Plasmablast\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLC38A5 PAOX BRCA2 RASGRP3 SHCBP1 BUB1	9.36e-06	198	109	6	b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast\|Leuk-UTI / Disease, condition lineage and cell class	SLC38A5 PNPO GSTM2 PAOX SHCBP1 SMOX	9.63e-06	199	109	6	1b17e6d5e6b994dec65efae2667f4f1f438161b1
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-erythrocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 NPTXR SMOX	1.31e-05	123	109	5	89415e47db7352ba385895e2127e683db131dc03
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	VWF LAYN SLC38A5 SEMA3G ARHGAP25	1.78e-05	131	109	5	308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	GHRL SPEF2 KLF1 CFAP206 FOXJ1	2.89e-05	145	109	5	ac41c6c02b7d78162b86222983688f54d04ac47d
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK\|Thalamus / BrainAtlas - Mouse McCarroll V32	VWF LAYN SEMA3G ISG15 ARHGAP25	3.98e-05	155	109	5	fe6c4aba0e98cda84bf178aeac2e9fa834477f22
ToppCell	368C-Myeloid-Dendritic-cDC1\|368C / Donor, Lineage, Cell class and subclass (all cells)	RELCH FLT3 GHRL DENND1B DHTKD1	4.36e-05	158	109	5	c276a259e20ee704e2d04baf693e8d677f96f654
ToppCell	Leuk-UTI-Lymphocyte-B-Plasmablast\|Leuk-UTI / Disease, Lineage and Cell Type	SLC38A5 PNPO GSTM2 SHCBP1 SMOX	4.36e-05	158	109	5	05a29c2d5506a25ccdfa4c6a86e9188977a18272
ToppCell	facs-Marrow-T-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	4.77e-05	161	109	5	79a4a81963c92ade5b6910816a440dc3c233ead2
ToppCell	facs-Marrow-T-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	4.77e-05	161	109	5	1ce40a6d0f0b9870e7ddb3d607668adcbd3dd1d3
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	5.21e-05	164	109	5	f3772227f5aa75a3672d945f8d5bf3fa0b4e456b
ToppCell	facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	5.84e-05	168	109	5	08fe8fa43c343c03f9a2f0b982192fde04a7c027
ToppCell	facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	5.84e-05	168	109	5	d4053b2fffb19e0376b8ceb92e87ec4447d96a3e
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF SLC38A5 SLC5A1 CITED2 DHTKD1	6.18e-05	170	109	5	7fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell	facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNPO COL18A1 ISG15 KLF1 SMOX	6.18e-05	170	109	5	b180ec9a1b79025a180c8559c27c31272410dea8
ToppCell	facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNPO COL18A1 ISG15 KLF1 SMOX	6.18e-05	170	109	5	37c647f67505aa1ff12a198df1eeddd9f406fe15
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SLC38A5 SEMA3G PAOX RASGRP3 SHCBP1	6.89e-05	174	109	5	bdbaf805a94b2f5a0065933dab6bf84e3cabd525
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	6.89e-05	174	109	5	81ab196e36cac2a7974d6e3fe457efffddfd03bb
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	7.28e-05	176	109	5	fc51e4dcad5456c229d76fdcb9a80c4c79eacf3f
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBTD2 NAP1L1 BRCA2 C7 DCTPP1	7.28e-05	176	109	5	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	droplet-Marrow-nan-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	7.28e-05	176	109	5	f92063b72ebfeb9b192281dc63d6bf2759c78554
ToppCell	droplet-Marrow-nan-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	7.68e-05	178	109	5	b4e15c176875cd226854a0019495309d02730c42
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC38A5 SEMA3G COL18A1 RASGRP3 BUB1	7.68e-05	178	109	5	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC38A5 SEMA3G COL18A1 RASGRP3 BUB1	7.68e-05	178	109	5	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	7.68e-05	178	109	5	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	droplet-Spleen-nan-24m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	7.88e-05	179	109	5	f3f9c7e575bc4d9d3bce649b90254182e8f6aaec
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NT5M ASPH PKD1 PLD1 DHTKD1	7.88e-05	179	109	5	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	droplet-Marrow-nan-24m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	7.88e-05	179	109	5	7e6da098976c7801d31dcc0201f813d2bc8b07fc
ToppCell	droplet-Spleen-nan-24m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO ISG15 KLF1 SMOX	7.88e-05	179	109	5	01e0b49e7f03ac9c3e6c34708ead300d27236b8b
ToppCell	P03-Epithelial-airway_epithelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	8.30e-05	181	109	5	1ea21d860d4d7abab3e21e130a16d044006656ee
ToppCell	P03-Epithelial-airway_epithelial_cell-club_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	8.30e-05	181	109	5	60a91587c59029a34e7bec1255083337fe21b72a
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF SEMA3G PARP14 ISG15 RASGRP3	8.52e-05	182	109	5	840427d1c23d60482c943ff006b14007ed44d247
ToppCell	NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FLT3 DNAJC13 PARP14 ISG15 CFAP206	8.52e-05	182	109	5	e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	MYH9 APOBEC3G PTCH1 PPP2R5C ARHGAP25	8.75e-05	183	109	5	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF SEMA3G CUBN ERVMER34-1 COL18A1	8.75e-05	183	109	5	ce8be9418b473ea94ec806edc7a2078cc30c1703
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PARP14 BRCA2 ISG15 RASGRP3 DHTKD1	8.75e-05	183	109	5	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 PNPO NPTXR SMOX	9.12e-05	96	109	4	7a1a27d996c2bbcd922da524969f568f0575dfad
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	9.20e-05	185	109	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	9.20e-05	185	109	5	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	9.44e-05	186	109	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	PND14-Epithelial-Epithelial_Airway\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	9.68e-05	187	109	5	1399c703505211c510b3f14c7a2aa9930566c473
ToppCell	droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC38A5 COL18A1 KLF1 BUB1 ASPH	9.93e-05	188	109	5	1a3f95b4fd7611c634666761ddf21f1e58e56af8
ToppCell	multiciliated\|World / shred by cell class for bronchial biopsy	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	9.93e-05	188	109	5	6833c1f0f265ef5448fa65033550ed7efc2f8d7b
ToppCell	facs-Lung-EPCAM-24m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GHRL MAB21L4 MYH14 CFAP206 FOXJ1	9.93e-05	188	109	5	c2ef270f691d367b1621d48f0771267cefe1630d
ToppCell	droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GHRL MAB21L4 MYH14 CFAP206 FOXJ1	9.93e-05	188	109	5	bc0b9ba8ae88e8a89e98b446584ed39606e4229e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYH7B PNPO GSTM2 RASGRP3 SHCBP1	9.93e-05	188	109	5	34873972dff9284dfcd26bb698c9d1df007f1cbb
ToppCell	droplet-Lung-1m-Epithelial-airway_epithelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GHRL MAB21L4 MYH14 CFAP206 FOXJ1	9.93e-05	188	109	5	50994e304c719f2f3c3232e48141e2dd15c96612
ToppCell	droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GHRL MAB21L4 MYH14 CFAP206 FOXJ1	9.93e-05	188	109	5	a7b7ba56603a8a50869b41902aed6a9ab1c5c021
ToppCell	PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.02e-04	189	109	5	057d7a03fdbe779122b203619a6f947f49b84d28
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.02e-04	189	109	5	b55de812043b670cbde810d7d42f45909b6d66ef
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	1.02e-04	189	109	5	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	Epithelial-D_(Ciliated)\|World / shred on cell class and cell subclass (v4)	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.02e-04	189	109	5	0bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCell	PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.02e-04	189	109	5	9f57a131902d23494bf389baf6e6e2d99f88b2c8
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.02e-04	189	109	5	4e83e49d1265ffe507fdb72924c77c4d1c73f0bd
ToppCell	PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.02e-04	189	109	5	e443b02502edaefa94567a9e8af5756e8e11ff30
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SLC38A5 PTCH1 GSTM2 COL18A1 C7	1.04e-04	190	109	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.04e-04	190	109	5	088e3f39a1e5e11354d6e7458e8e6a39f14936b3
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.04e-04	190	109	5	35248a8be476ea8d06d67c3d98a25be1f7c150b7
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A6 NAP1L1 SLC38A5 CITED2 C7	1.04e-04	190	109	5	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	SLC38A5 CITED2 SHCBP1 SMOX PRRC1	1.04e-04	190	109	5	ce70336679a2b713836e7497e6dc48aac612b018
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.04e-04	190	109	5	5f5206f9e725070d865f4c891ff08bb750e58582
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF PARP14 ISG15 RASGRP3 FUT2	1.04e-04	190	109	5	2655df8c0883dd811fa7617301f9c4b0a4dd55ec
ToppCell	PND07-Epithelial-Epithelial_Airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.07e-04	191	109	5	b55500eb416f4f339031acad16b2737e5b891d8e
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 GHRL SPEF2 CFAP206 FOXJ1	1.07e-04	191	109	5	96483adb97c81208aa513782550acd8a08b63866
ToppCell	Ciliated-cil-3\|World / Class top	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	1.10e-04	192	109	5	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	COVID-19_Severe-Lymphoid_P\|COVID-19_Severe / Disease group, lineage and cell class	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.10e-04	192	109	5	3d0240491296757b3125f6e861bbaca06bbc5068
ToppCell	COVID-19_Severe-Lymphoid_P-Plasmablast\|COVID-19_Severe / Disease group, lineage and cell class	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.10e-04	192	109	5	90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.12e-04	193	109	5	227d82059a9f99937e0188ff57f2d0e485ebfe69
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.12e-04	193	109	5	38bb14df7f05c29565a1c7f175fafe636e543bf8
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	1.12e-04	193	109	5	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWF SEMA3G COL18A1 LIMK2 RASGRP3	1.12e-04	193	109	5	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	APOBEC3G PPP2R5C ISG15 ARHGAP25 ATM	1.12e-04	193	109	5	fce4f805e53669acb4c188f87ac7d84408c0c218
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.12e-04	193	109	5	3ba6d44248690b80f4caf791d463e60f1ab816c4
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	APOBEC3G PPP2R5C ISG15 ARHGAP25 ATM	1.12e-04	193	109	5	6e1498153a7766c03fddbda1701dbf1596d21736
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.12e-04	193	109	5	ce3873ece35fd2155ea235cb3c8bcd235cc0ebde
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COPB2 SLC38A5 RASGRP3 SHCBP1 BUB1	1.12e-04	193	109	5	8f57b0473a2c2c07f83e5fe70f16862b1bb3b514
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	APOBEC3G GSAP ISG15 ATM STARD3NL	1.15e-04	194	109	5	a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPEF2 CFAP206 DNAH11 FOXJ1	1.15e-04	194	109	5	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GSAP PTCH1 SBF2 ARHGAP25 STARD3NL	1.15e-04	194	109	5	a8dc3336aa4ef497f6d26cede02ddac425e7c655
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	APOBEC3G GSAP ISG15 ATM STARD3NL	1.15e-04	194	109	5	0abca32c3547a45cebab0bd69c1f7a0002deaa80
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC38A5 BRCA2 RASGRP3 SHCBP1 BUB1	1.18e-04	195	109	5	c6e31038be2463f1601d52c82efa4e9facb8228f
ToppCell	15-Trachea-RBC-RBC\|Trachea / Age, Tissue, Lineage and Cell class	SLC38A5 KLF1 SHCBP1 BUB1 SMOX	1.21e-04	196	109	5	511bfc06c34d5add2ae561cca463d1e4e2d43e20
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A6 NAP1L1 SLC38A5 CITED2 C7	1.21e-04	196	109	5	6730743cf088c419ccc2d28765769fc09d3ba6a7
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	PLXNA3 MAB21L4 GON4L PTPN21 PTCH1 RAB3GAP2 ASPH ATM FGGY	4.08e-07	198	107	9	4790_DN
Drug	Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A	SARM1 GON4L APOBEC3G ORC4 NPTXR RAB3GAP2 ASPH ATM	4.27e-06	197	107	8	1802_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A	GLB1L SARM1 INTS1 SEMA3G PTPN21 PAOX RAB3GAP2 ZNF44	4.60e-06	199	107	8	4749_UP
Drug	NSC107658	MYH9 MYH7B SLC5A1 PTK2B LIMK2 CSF2 MYH14 PLD1 MMP13	1.44e-05	306	107	9	CID000002919
Drug	AC1L1C3U	CYP19A1 ATM	2.19e-05	2	107	2	CID000001728
Drug	nifedipine	HJV MYH9 VWF MYH7B CYP19A1 CYP39A1 PTK2B MYH14 PKD1 CYP4F12	2.65e-05	415	107	10	CID000004485
Drug	ATP,Gamma S	NAP1L1 PAOX UBA1 P2RY4 P2RY11 ATM EP300	3.15e-05	189	107	7	CID000002028
Drug	Sotalol hydrochloride [959-24-0]; Down 200; 13uM; PC3; HT_HG-U133A	GON4L PTPN21 ATP8B2 NT5M SYNJ1 KLF1 RAB3GAP2	4.10e-05	197	107	7	4079_DN
Drug	troglitazone; Up 200; 10uM; SKMEL5; HG-U133A	FLT3 CASR PTPN21 CUBN PAOX ASPH FUT2	4.10e-05	197	107	7	504_UP
Drug	Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A	SARM1 APOBEC3G LCT SLC5A1 PTK2B MYH14 PLD1	4.10e-05	197	107	7	6383_DN
Drug	Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; PC3; HT_HG-U133A	GLB1L CYP19A1 SARM1 APOBEC3G SEMA3G CHRNB3 PTK2B	4.23e-05	198	107	7	4062_UP
Drug	Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A	GON4L CASR PTCH1 PAOX BUB1 ASPH MMP13	4.23e-05	198	107	7	7322_UP
Drug	phenylhydrazine	HJV PLEKHG4 PAOX KLF1 SMOX	4.27e-05	82	107	5	CID000007516
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SARM1 CYP39A1 ATP8B2 CHRNB3 PTK2B KLF1 ASPH	4.37e-05	199	107	7	3203_UP
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ENGASE ATP8B2 CITED2 EPS15L1 LIMK2 MYH14 NPTXR	4.37e-05	199	107	7	1054_UP
Drug	bromouridine	APOBEC3G P2RY4 P2RY11 DYNC1H1	4.94e-05	43	107	4	CID000091494
Disease	total blood protein measurement	DNAH3 FLT3 DNAJC13 CORO1C CYP19A1 SLC38A5 CITED2 EPS15L1 RASGRP3 SBF2 PKD1	7.49e-07	449	107	11	EFO_0004536
Disease	neuroimaging measurement	CORO1C PTPN21 PTCH1 MFSD4B CHRNB3 COL18A1 DENND1B SEC14L6 SYNJ1 RASGRP3 RAB3GAP2 PKD1 PLD1 DNAH11 FOXJ1	7.38e-06	1069	107	15	EFO_0004346
Disease	Cataract	MYH9 INTS1 COL18A1 ATM	9.84e-06	37	107	4	C0086543
Disease	melanoma	EIF1AD CUBN PTK2B CSF2 BRCA2 ATM EP300	3.48e-05	248	107	7	C0025202
Disease	Malignant neoplasm of pancreas	PTCH1 BRCA2 BUB1 ATM EP300	3.59e-05	102	107	5	C0346647
Disease	leukemia inhibitory factor measurement	SARM1 SMOX	7.78e-05	4	107	2	EFO_0801764
Disease	osteosarcoma (implicated_via_orthology)	CITED2 BRCA2	7.78e-05	4	107	2	DOID:3347 (implicated_via_orthology)
Disease	whole-brain volume	CUBN DNAH11	1.29e-04	5	107	2	EFO_0005089
Disease	hypertension (biomarker_via_orthology)	VWF CYP19A1 GSTM2 PTK2B CYP4F12 EP300	1.84e-04	227	107	6	DOID:10763 (biomarker_via_orthology)
Disease	ERO1-like protein alpha measurement	SARM1 C7	1.94e-04	6	107	2	EFO_0801582
Disease	protocadherin beta-4 measurement	SARM1 C7	1.94e-04	6	107	2	EFO_0801976
Disease	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement	SARM1 C7	1.94e-04	6	107	2	EFO_0801372
Disease	HOMA-IR	SPEF2 COPB2 FGGY	2.34e-04	33	107	3	EFO_0004501
Disease	obsolete_Fms-related tyrosine kinase 3 ligand measurement	FLT3 NT5M	2.70e-04	7	107	2	EFO_0010594
Disease	infertility (implicated_via_orthology)	BRCA2 ATM	2.70e-04	7	107	2	DOID:5223 (implicated_via_orthology)
Disease	duodenal ulcer	FLT3 PLD1 FUT2	3.03e-04	36	107	3	EFO_0004607
Disease	endometrial cancer (is_implicated_in)	CYP19A1 BRCA2 ATM	3.03e-04	36	107	3	DOID:1380 (is_implicated_in)
Disease	cytoskeleton-associated protein 2 measurement	MYH9 SARM1	3.60e-04	8	107	2	EFO_0020309
Disease	zinc-alpha-2-glycoprotein measurement	SARM1 C7	3.60e-04	8	107	2	EFO_0802228
Disease	lactase-phlorizin hydrolase measurement	LCT FUT2	3.60e-04	8	107	2	EFO_0801753
Disease	kidney disease (implicated_via_orthology)	MYH9 CUBN LCT	4.47e-04	41	107	3	DOID:557 (implicated_via_orthology)
Disease	complement C1q and tumor necrosis factor-related protein 9A measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0803293
Disease	dickkopf-like protein 1 measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0020324
Disease	cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0020296
Disease	cellular retinoic acid-binding protein 1 measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0801463
Disease	oxysterols receptor LXR-beta measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0801865
Disease	apolipoprotein D measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0020156
Disease	interleukin-34 measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0020505
Disease	leucine-rich repeat serine/threonine-protein kinase 2 measurement	SARM1 C7	4.61e-04	9	107	2	EFO_0021876
Disease	renal cell carcinoma	ANAPC16 ATM PLD1	4.80e-04	42	107	3	EFO_0000681
Disease	Pancreatic Neoplasm	PTCH1 BRCA2 ATM EP300	4.90e-04	100	107	4	C0030297
Disease	Bone Resorption	GHRL CYP19A1	5.75e-04	10	107	2	C0005974
Disease	serine/threonine-protein kinase 16 measurement	SARM1 C7	5.75e-04	10	107	2	EFO_0020724
Disease	interleukin-37 measurement	SARM1 C7	5.75e-04	10	107	2	EFO_0020506
Disease	insulin growth factor-like family member 3 measurement	SARM1 C7	5.75e-04	10	107	2	EFO_0801700
Disease	end stage renal disease (is_marker_for)	VWF GHRL CASR	6.28e-04	46	107	3	DOID:783 (is_marker_for)
Disease	Primary Ciliary Dyskinesia	SPEF2 DNAH11 FOXJ1	6.69e-04	47	107	3	C4551720
Disease	cocaine use	CHRNB3 STARD3	7.01e-04	11	107	2	C3496069
Disease	tumor necrosis factor receptor superfamily member 11B measurement	SARM1 C7	7.01e-04	11	107	2	EFO_0020801
Disease	interleukin-22 receptor subunit alpha-2 measurement	FLT3 SARM1	7.01e-04	11	107	2	EFO_0020500
Disease	interleukin-10 receptor subunit alpha measurement	SARM1 C7	7.01e-04	11	107	2	EFO_0021890
Disease	guanylate-binding protein 6 measurement	SARM1 C7	7.01e-04	11	107	2	EFO_0801662
Disease	glycerol-3-phosphate dehydrogenase 1-like protein measurement	SARM1 C7	7.01e-04	11	107	2	EFO_0801640
Disease	Medulloblastoma	PTCH1 BRCA2 ATM	8.03e-04	50	107	3	C0025149
Disease	serine protease 27 measurement	SARM1 FUT2	8.40e-04	12	107	2	EFO_0008280
Disease	Dental enamel hypoplasia	MYH7B MYH14	8.40e-04	12	107	2	EFO_1001304
Disease	complement component C7 measurement	SARM1 C7	8.40e-04	12	107	2	EFO_0008093
Disease	retinal drusen	ENGASE VWF PTK2B	8.51e-04	51	107	3	EFO_1001155
Disease	spine bone mineral density	CYP19A1 PTCH1 ARHGAP25 STARD3NL	9.42e-04	119	107	4	EFO_0007701
Disease	kallikrein-12 measurement	SARM1 C7	9.90e-04	13	107	2	EFO_0008194
Disease	Benign tumor of pancreas	BRCA2 EP300	9.90e-04	13	107	2	C0347284
Disease	Squamous cell carcinoma	PTCH1 UBA1 ATM EP300	1.10e-03	124	107	4	C0007137
Disease	silicosis (biomarker_via_orthology)	CSF2 MMP13	1.15e-03	14	107	2	DOID:10325 (biomarker_via_orthology)
Disease	Kartagener syndrome (implicated_via_orthology)	DNAH11 FOXJ1	1.15e-03	14	107	2	DOID:0050144 (implicated_via_orthology)
Disease	glucose homeostasis measurement, glucose effectiveness measurement	MYH7B MYH14	1.33e-03	15	107	2	EFO_0006833, EFO_0006896
Disease	Proteinuria	VWF CUBN	1.33e-03	15	107	2	HP_0000093
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	VWF LIMK2	1.51e-03	16	107	2	EFO_0004569, MONDO_0009354
Disease	Profound Mental Retardation	GON4L CHD8 COL18A1 DYNC1H1	1.67e-03	139	107	4	C0020796
Disease	Mental Retardation, Psychosocial	GON4L CHD8 COL18A1 DYNC1H1	1.67e-03	139	107	4	C0025363
Disease	Mental deficiency	GON4L CHD8 COL18A1 DYNC1H1	1.67e-03	139	107	4	C0917816
Disease	SLAM family member 7 measurement	SARM1 C7	1.71e-03	17	107	2	EFO_0008287
Disease	primary ciliary dyskinesia (implicated_via_orthology)	SPEF2 FOXJ1	2.14e-03	19	107	2	DOID:9562 (implicated_via_orthology)
Disease	Pancreatic carcinoma	BRCA2 EP300	2.14e-03	19	107	2	C0235974
Disease	glomerulonephritis (is_marker_for)	PTK2B EP300	2.14e-03	19	107	2	DOID:2921 (is_marker_for)
Disease	breast cancer (is_implicated_in)	CYP19A1 PTK2B BRCA2 ATM	2.21e-03	150	107	4	DOID:1612 (is_implicated_in)
Disease	cardiomyopathy (implicated_via_orthology)	MYH7B CASR COL18A1	2.22e-03	71	107	3	DOID:0050700 (implicated_via_orthology)
Disease	Adenocarcinoma of prostate	BRCA2 ATM	2.37e-03	20	107	2	C0007112
Disease	BREAST CANCER	BRCA2 ATM	2.62e-03	21	107	2	114480
Disease	esophagus adenocarcinoma (is_implicated_in)	GHRL CYP19A1	2.62e-03	21	107	2	DOID:4914 (is_implicated_in)
Disease	gastric ulcer (biomarker_via_orthology)	COL18A1 MMP13	2.62e-03	21	107	2	DOID:10808 (biomarker_via_orthology)
Disease	Parkinson's disease (is_implicated_in)	DNAJC13 SYNJ1 ATM	2.69e-03	76	107	3	DOID:14330 (is_implicated_in)
Disease	monocyte count	FLT3 SPEF2 GON4L APOBEC3G LCT GSTM2 PTK2B PKD1 ARHGAP25 ATM STARD3NL FGGY	3.02e-03	1320	107	12	EFO_0005091
Disease	lung squamous cell carcinoma (is_implicated_in)	PTCH1 ATM	3.41e-03	24	107	2	DOID:3907 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IWDLADPEGKGFLDK	EPS15L1	56	Q9UBC2
GDFWPNVLEESIKEL	EP300	1506	Q09472
WLPDIVLFENADGRF	CHRNB3	111	Q05901
GDENIKGFIWDLISP	CHD8	1496	Q9HCK8
ADEWRFKPIEQLLGF	ANAPC16	91	Q96DE5
FIVGNPWDDKLIFKL	BUB1	736	O43683
NLFPGLKEAFVVEEW	COPB2	796	P35606
CFLDVIPFWKLDLDQ	APOBEC3G	261	Q9HC16
KEIEFLSWTEPFGIA	CASR	601	P41180
EWFEGKNADPILISL	CORO1C	376	Q9ULV4
EEKPRELWIFDFPAQ	DNAH11	1726	Q96DT5
VLFDFVSDPLSDLKW	PPP2R5C	51	Q13362
LFLPEDENLREKGDW	ASPH	611	Q12797
KLLPLWEAQFGDFFN	DHTKD1	656	Q96HY7
FLLIEAADFLPKWLD	ECD	116	O95905
ADKKFLFWDPSLLEA	ATP8B2	461	P98198
NVADFRKLEWLFPET	CFAP206	391	Q8IYR0
RVQGAWPLLDNDFLF	HJV	186	Q6ZVN8
GIPEFWLTVFKNVDL	NAP1L1	166	P55209
SDIDLVVFGKWENLP	TENT4B	176	Q8NDF8
LPAEFPDKVFAEKWN	ORC4	236	O43929
FGKDQDWPALAVDLA	RAB3GAP2	1246	Q9H2M9
QDFELWDDVGLNIPK	RELCH	286	Q9P260
VLFLAPEDWAELQGA	MAB21L4	306	Q08AI8
DKLSGFQGDFLWPIL	P2RY11	21	Q96G91
GPLFEEELAFWGIDE	KCNC2	131	Q96PR1
FQALLDIWFPEEKPL	INTS1	1186	Q8N201
VTFLKALGDSEWFPQ	SBF2	1371	Q86WG5
LQKEGFWPEAFSEVA	EIF1AD	96	Q8N9N8
PRTLDFGLNVKLFWE	LIMK2	551	P53671
EKFIENLLPSDGDFW	LAYN	91	Q6UX15
VPLLDWQGIFAKVGD	ERVMER34-1	471	Q9H9K5
GVQDDLFWLTFEGKP	ISG15	116	P05161
LFWLTFEGKPLEDQL	ISG15	121	P05161
FWDVVLGFPLDLQKK	HECTD2	691	Q5U5R9
EGIPWTFLDFGLDLQ	MYH14	521	Q7Z406
IDWVFIDFGLDLQPC	MYH7B	551	A7E2Y1
LDFSVVWDGDFPIDK	PLXNA3	761	P51805
VDAELFLTKSFWPEL	MMP13	316	P45452
KDELLFPSWEALFSG	COL18A1	1646	P39060
PWFLGDKITFVDFIA	GSTM2	146	P28161
LGDKVKFWITLNEPF	LCT	1526	P09848
GIEWNFIDFGLDLQP	MYH9	496	P35579
LDPVKQFAAWFEEAV	PNPO	56	Q9NVS9
NVLPWEDKLVEAFGG	NPTXR	471	O95502
EALFGVPNDKNLLWA	MFSD4B	171	Q5TF39
QDFLQKFALFPVGWL	PTPN21	161	Q16825
KFALFPVGWLQDEKV	PTPN21	166	Q16825
DCWFDEDFKFILLPV	P2RY4	26	P51582
PFEESLDLPLWKFLQ	PARP14	321	Q460N5
FLLEWFAVDAPDGVL	CUBN	1956	O60494
LKWEFPRENLEFGKV	FLT3	601	P36888
VADFDLGKDVLPWLR	GSAP	6	A4D1B5
DKENPFEGLDDINLW	ATM	1781	Q13315
NLKDFLLVIPFDCWE	CSF2	126	P04141
ALGPFPDTQDDFLKW	KLF1	16	Q13351
KADLGPISLNWFEEL	BRCA2	21	P51587
KVWLIDFNPFGEVTD	CDC123	241	O75794
FDAWQALLIKPDIFF	CYP19A1	221	P11511
LARLTFFQEWIDKGP	DNAH3	3946	Q8TD57
FLQDILWEEAKEAPA	GHRL	101	Q9UBU3
GVLLAFADQPIKNWE	FGGY	31	Q96C11
FLKIFKPEAAFLPEW	FUT2	316	Q10981
DNLFIRFLKPWLGEG	CYP4F12	121	Q9HCS2
NPEFLQLAEPFWKEL	C7	266	P10643
DFLAAVDSWFKVLLP	GLB1L	151	Q6UWU2
DWPQLLKDFAAFLLP	GON4L	1681	Q3T8J9
ELEPLKGNFDWEAIF	FOXJ1	301	Q92949
WKLPEDFAVVFGEAE	DNAJC13	1961	O75165
LSWKEFLPEGQDIGA	EIF4G1	1401	Q04637
GKWLVLFCDEINLPD	DYNC1H1	2656	Q14204
WFLELFEKNIPDIKA	CYP39A1	221	Q9NYL5
WFSILPDFSLDLQEG	ELP5	216	Q8TE02
EELLAWKPRLEDGFN	ENGASE	91	Q8NFI3
ELAELFQWKTDGEPG	DCTPP1	66	Q9H773
FGKQPFFWLENKDVI	PTK2B	621	Q14289
VLWKFPEDFGDQEIL	DENND1B	31	Q6P3S1
RDLWKPGIELLQEFF	SEC14L6	161	B5MCN3
FVFSLGPIWDDKELE	COL6A6	2116	A6NMZ7
LGWEPLKVLLEALYF	PKD1	3601	P98161
NKIFLEFEEPFWEPD	PAOX	321	Q6QHF9
NLETLDFKEWVEFSP	PLA2G4D	471	Q86XP0
WESKNFFFELEPLPG	NT5M	96	Q9NPB1
ILELYDWNLKGPLFE	DROSHA	656	Q9NRR4
GLWFTGDEDIKIPEN	SPEF2	1581	Q9C093
WFPVFRDLVNIGLKA	TMEM43	336	Q9BTV4
WLLDAPKLAGIQEFQ	SYNJ1	561	O43426
KFLQPLTGWEAAELD	PLEKHG4	511	Q58EX7
DWVQLDKPFADFIDR	PLD1	656	Q13393
DPEGDWFLKGNLLII	SLC38A5	161	Q8WUX1
WILKFPAEFNLDLGL	RASGRP3	81	Q8IV61
WTNFDPLEFLEELKK	PTCH1	256	Q13635
AWFALGIDPIAAEEF	NUDT12	226	Q9BQG2
VENFIAELLPDKWFD	PRRC1	331	Q96M27
FTAEFLEKVLEPSGW	SHCBP1	101	Q8NEM2
FWEDPQLALHKDFLT	SOWAHB	616	A6NEL2
TWFLDFKVLPQEAEE	STARD3	166	Q14849
KELPELWLGQNEFDF	CITED2	241	Q99967
KEFFWNVEEDFKPAP	C12orf29	101	Q8N999
LAEPRVEDFGNAWKL	VWF	541	P04275
AEWLFPLAFSKEDEL	SARM1	251	Q6SZW1
IETWFLDFKVLPQEA	STARD3NL	166	O95772
PSDEKLEEFWIDFNL	SYCP2	296	Q9BX26
EAGKFVFEIIPASWD	ARHGAP25	106	P42331
APAFEGRKEIWDALK	UBTD2	61	Q8WUN7
FAQDLWPEQGIKDSF	ZNF723	81	P0DPD5
DKIFLEFEEPFWGPE	SMOX	366	Q9NWM0
DLNEASKWILDPFLF	ZBED8	466	Q8IZ13
SKWILDPFLFNIDFV	ZBED8	471	Q8IZ13
GFDILIDDNLKPWLL	TTLL2	371	Q9BWV7
QWARDEFEGLFKQPA	UBA1	646	P22314
FDQLEDVFLLWPKAG	SEMA3G	306	Q9NS98
FLLAIFWKRVNEPGA	SLC5A1	471	P13866
LEWGLPKDQDSVAFE	ZNF44	41	P15621